Differences in clinical and endocrine features between obese and non-obese women in polycystic ovarian syndrome

Awat Ibrahim  Hamadamen; Zhyan Baker  Hasan; Jalal Abdullah Hasan  Albazaz; Rebaz Tahir  Lak

doi:10.56056/amj.2017.23

Authors

Awat Ibrahim Hamadamen Lecturer, College of medicine\OBGYN department
Zhyan Baker Hasan Private Hawler Center for Infertility and IVF
Jalal Abdullah Hasan Albazaz Diagnostic Radiologist, Erbil Teaching Hospital
Rebaz Tahir Lak Lecturer, Kurdistan Board of Medical Specialties, Planning Department. Erbil-Iraq

DOI:

https://doi.org/10.56056/amj.2017.23

Keywords:

Amenorrhea, hirsutism, obesity, polycystic ovarian syndrome

Abstract

Background and objectives: The polycystic ovary syndrome is one of the commonest endocrine disturbance affecting 5-8% of reproductive age women. It is a heterogenous disorder that mainly presents with features of hyperandro- genism and anovulation. These clinical features are further affected by body mass index at presentation. This study aimed to estimate the impact of obesity on the clinical features of polycystic ovary syndrome and to compare hor- monal and ultrasonography features between obese and non-obese polycystic ovary syndrome women.

Methods: a cross-sectional comparative study carried on 230 infertile women with criteria of polycystic ovary syndrome attend- ing Private Hawler Centre for Infertility and in vitro fertilization, Erbil, Iraq, in the period between the 1st of October 2015 and the 1st of April 2016.

Results: Out of 230 polycystic ovarian syndrome women, the BMI was 25 kg/m² in 123 ladies (53.48%); 32 ladies 13.9% were overweight and 91 ladies 39.5% were obese. Obese polycystic ovary syndrome women had more sedentary life, more family history of polycystic ovary syndrome and associated with higher miscarriage rate. Amenorrhea and oligomenorrhoea were found more frequently in obese women 24.4% and 62.6% respectively than non-obese polycystic ovary syndrome women 21.5% and 53.3%.

Conclusions: Obesity has a significant impact on the appearance of clinical features of polycystic ovary syndrome among infertile women, signs of hyperandrogenism, maximum ovarian volume and mean serum level of hormones including luteinizing hormone, progesterone and testosterone were significantly more reported in obese than non-obese polycystic ovary syndrome women.

Downloads

Download data is not yet available.

References

Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J ClinEndocrinolMetab. 2004;89: p.2745–49.

Zawadzki J, Dunaif A.Diagnostic Criteria for polycystic ovary syn- drome: towards a rational approach. In : Dunaif A, Givens JR, Haseltine FP, Merriam GR (eds). Polycystic ovary syndrome. Oxford;1992: Black- well Scientific Publications p.377–84.

Franks S. Polycystic ovary syndrome. Engl J Med N. 1995;333: p.853–61.

Ehrmann DA. Polycystic ovary syndrome. N Engl J Med. 2005;352: p.1223–36.

B. C. J. M. Fauser. “Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fer- tility and Sterility. 2004;81(1):p. pp.19–24.

Legro RS, Strauss JF. Molecular progress in infertility: polycystic ovary syndrome. FertilSteril. 2002;78:p.569-76.

Doi SA, Al-Zaid M, Towers PA, Scott CJ, Al-Shoumer KA. Ovarian steroids modulate neuroendocrine dysfunction in polycystic ovary syndrome. J Endocrinol Invest.2005; 28: p.882-92.

Bagatell CJ, Bremner WJ. Androgens in men – uses and abuses. N Engl J Med. 1996;334: p. :707–14.

Gambineri A, Pelusi C, Vicennati V, Pagotto U, Pasquali R. Obesity and the polycystic ovary syndrome. Int J Obesity. 2002; 26(7 ): p.883–96.

Kiddy DS, Hamilton-Fairley D, Bush A, Short F, Anyaoku V, Reed MJ, et al. Improvement in endocrine and ovarian function during di- etary treatment of obese women with polycystic ovary syndrome. ClinEndocrinol.1992;36: p.105–11.

Holte J, Bergh T, Berne C, Wide L, Lithell H. Restored insulin sen- sitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome. J ClinEndo- crinolMetabo.l 1995;80: p. 2586–93.

Ewens K, Jones M, Ankener W et al. “FTO and MC4R gene variants are associated with obesity in polycystic ovary syndrome. ” PLoS One. 2011;6(1):p.Article IDe16390.

Majumdar A and Singh T. Comparison of clinical features and health manifestations in lean vs. obese Indian women with polycystic ovarian syndrome. J Hum Reprod Sci. 2009; 2(1): p.:12–17.

Sotoudeh G, Mirdamadi SR, Siassi F, Khosravi S and Chamari M. Relationships of overweight and obesity with hormonal and metabolic parameters in hirsute women.Actamedicairanica. 2003; 41: p.37-44.

Hatch R, Rosenfield RL, Kim MH, Tredway D. Hirsuitism: implica- tions, etiology, and management. AmJ ObstetGynecol. 1981;140: p.815_30.

Solomon TP, Haus JM, Kelly K R, Cook M D, Riccardi M, Rocco M, et al. Randomized trial on the effects of a 7-d low glycemic dietand exercise intervention on insulin resistencein old obese humans. Am J ClinNutr.2009; 90:p.1222-9.

Thathapudi S, Kodati V, Erukkambattu J, Katragadda A, Addepally U, Hasan Q. Anthropometric and Biochemical characteristics of pol- ycystic ovarian syndrome in south Indian women using AES–2006 criteria. Int J Endocrinol Metab. 2014. January;12(1): p.e12470.

Mahmoud M, Habeeb F, Kasim K. Reproductive and biochemical changes in obese and non obese polycystic ovary syndrome women. Alexandria Journal Of medicine.2015;51:p.5-9.

Wang JX, Davies MJ, Norman RJ. Obesity increases the risk of spontaneous abortion during infertility treatment..Obes Res. 2002; 10(6):p.551-4.

Ozgun MT1, Uludag S, Oner G, Batukan C, Aygen EM, Sahin Y. The influence of obesity on ICSI outcomes in women with polycystic ovary syndrome.. J ObstetGynaecol. 2011; 31(3):p.245-9.

Zhang YW, Stern B, Rebar RW. Endocrine comparison of obese menstruating and amenorrheic women. J ClinEndocrinolMetab. 1984;58:p.1077–83.

Hosseinian AH, Kim MH, Rosenfield RL. Obesity and oligomenor- rhea are associated with hyperandrogenism independent of hirsutism. J ClinEndocrinolMetab. 1976;42: p.765–69.

Silfen M, Denburg M, Manibo, Lobo R, Jafef R, Ferin M, Levine L, Oberfield S. Early Endocrine, Metabolic, and Sonographic Characteris- tics of Polycystic Ovary Syndrome (PCOS): Comparison between Non- obese and Obese Adolescents. The Journal of Clinical Endocrinology & Metabolism. 2003; 88(10): p.4682–88.

Pasquali R, Casimirri F, Cantobelli S, LabateMorselli AM, Venturoli S, Paradisi R, et al. Insulin and androgen relationships with abdomi- nal body fat distribution in women with and without hyperandrogen- ism39. Horm Res. 1993;39:p.179–87.